Hsa_circ_0032131 knockdown inhibits osteoarthritis progression via the miR-502-5p/PRDX3 axis

被引:13
|
作者
Xu, Jin [1 ]
Ma, Xinlong [1 ]
机构
[1] Tianjin Hosp, Dept Pain Treatment, Tianjin 300211, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 11期
关键词
circRNA; OA; NF-KAPPA-B; MATRIX DEGRADATION; II COLLAGEN; CHONDROCYTES; APOPTOSIS; CARTILAGE; INFLAMMATION; EXPRESSION; AGGRECAN; SPONGE;
D O I
10.18632/aging.203073
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteoarthritis (OA) is a chronic disease characterized by progressive loss of cartilage and failure of the diarthrodial joint. Circular RNAs (circRNAs) are known to participate in the pathogenesis of multiple diseases, including OA. We investigated the functions of hsa_circ_0032131, a circRNA upregulated in OA, using CHON-001 cells and an in vivo OA rat model. CHON-001 cells were treated with interleukin (IL) -113 to mimic OA in vitro. IL 113 -induced inhibition of CHON-001 growth was reversed by silencing hsa_circ_0032131. In addition, hsa_circ_0032131 knockdown reversed IL-113 -induced activation of Trx1, Cyclin D and PRDX3, whereas overexpression of PRDX3, a direct target of miR-502-5p, reversed this effect. Hsa_circ_0032131 served as a competing endogenous RNA for miR-502-5p. Moreover, knockdown of hsa_circ_0032131 attenuated OA symptoms in vivo by inactivating the STAT3 signaling pathway. Thus, silencing of hsa_circ_0032131 inhibited the progression of OA by inactivating the miR-502-5p/PRDX3/Trx1/STAT3 axis, which highlights its potential as a therapeutic target for OA.
引用
收藏
页码:15100 / 15113
页数:14
相关论文
共 50 条
  • [41] Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis
    Yang, Xi
    Zhang, Qunxiong
    Guan, Bugao
    ONCOTARGETS AND THERAPY, 2020, 13 : 11445 - 11457
  • [42] Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression
    Huang, Jing
    Zhou, Hongchi
    Diao, Yun
    Yang, Zhiming
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [43] Circ_0007444 Inhibits the Progression of Ovarian Cancer via Mediating the miR-570-3p/PTEN Axis
    Wu, Xinyu
    Liu, Daoyan
    Wang, Shuzhen
    Liu, Jie
    ONCOTARGETS AND THERAPY, 2021, 14 : 97 - 110
  • [44] Circular RNA hsa_circ_0084054 promotes the progression of periodontitis with diabetes via the miR-508-3p/PTEN axis
    He, Linlin
    Liu, Chengcheng
    Liu, Yiying
    Cheng, Guoping
    Zhang, Ping
    Guo, Shujuan
    Ding, Yi
    JOURNAL OF PERIODONTAL RESEARCH, 2023, 58 (04) : 827 - 840
  • [45] Hsa_circ_0079480 promotes tumor progression in acute myeloid leukemia via miR-654-3p/HDGF axis
    Hu, Qingzhu
    Gu, Yueli
    Chen, Shuxia
    Tian, Ying
    Yang, Shuo
    AGING-US, 2021, 13 (01): : 1120 - 1131
  • [46] Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis
    Zhang, Hongbin
    Dai, Qun
    Zheng, Lihua
    Yuan, Xiaofeng
    Pan, Shunwen
    Deng, Jingyi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (03) : 501 - 509
  • [47] Hsa_circ_0003928 regulates the progression of diabetic nephropathy through miR-136-5p/PAQR3 axis
    W. Zhang
    L. Zhang
    Q. Dong
    X. Wang
    Z. Li
    Q. Wang
    Journal of Endocrinological Investigation, 2023, 46 : 2103 - 2114
  • [48] Knockdown of MALAT1 Inhibits the Progression of Chronic Periodontitis via Targeting miR-769-5p/HIF3A Axis
    Chen, Qinchao
    Cao, Meng
    Ge, Hanyi
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [49] Hsa_circ_0021205 enhances lipolysis via regulating miR-195-5p/HSL axis and drives malignant progression of glioblastoma
    Suwen Li
    Jiaqi Yuan
    Zhe Cheng
    Yongdong Li
    Shan Cheng
    Xinglei Liu
    Shilu Huang
    Zhipeng Xu
    Anyi Wu
    Liang Liu
    Jun Dong
    Cell Death Discovery, 10
  • [50] Hsa_circ_0003928 regulates the progression of diabetic nephropathy through miR-136-5p/PAQR3 axis
    Zhang, W.
    Zhang, L.
    Dong, Q.
    Wang, X.
    Li, Z.
    Wang, Q.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (10) : 2103 - 2114